05/29/2026
The UK's new screening programme will reach a few thousand men per year while 55,000 are diagnosed annually. The tools to do far better — polygenic risk scoring, multi-marker blood tests, precision MRI, and consistent active surveillance — already exist, are largely within NICE approvals, and are supported by compelling trial evidence. Here is the architecture of what an evidence-optimised system would build right now. https://ipcsg.blogspot.com/2026/05/the-uks-nhs-could-do-much-better-and-so.html